NCT05679921 2025-07-16Pazopanib With or Without Pembrolizumab for Metastatic Soft Tissue SarcomaYonsei UniversityPhase 2 Recruiting116 enrolled
NCT06816771 2025-02-10Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or AdolescentsShandong Cancer Hospital and InstitutePhase 2 Recruiting38 enrolled
NCT06739395 2024-12-18Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment ExhaustionTianjin Medical University Second HospitalPhase 2 Recruiting300 enrolled